- Home
- CVAC vs NMFC Comparison
CVAC vs NMFC Comparison
Compare CVAC & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NMFC
- Stock Information
- Founded
- CVAC 2000
- NMFC 2010
- Country
- CVAC Germany
- NMFC United States
- Employees
- CVAC N/A
- NMFC N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NMFC Finance/Investors Services
- Sector
- CVAC Health Care
- NMFC Finance
- Exchange
- CVAC Nasdaq
- NMFC Nasdaq
- Market Cap
- CVAC 1.2B
- NMFC 983.8M
- IPO Year
- CVAC 2020
- NMFC 2011
- Fundamental
- Price
- CVAC $5.34
- NMFC $9.62
- Analyst Decision
- CVAC Hold
- NMFC Hold
- Analyst Count
- CVAC 3
- NMFC 4
- Target Price
- CVAC $6.83
- NMFC $10.00
- AVG Volume (30 Days)
- CVAC 574.2K
- NMFC 596.5K
- Earning Date
- CVAC 11-12-2025
- NMFC 11-03-2025
- Dividend Yield
- CVAC N/A
- NMFC 13.43%
- EPS Growth
- CVAC N/A
- NMFC N/A
- EPS
- CVAC 1.01
- NMFC 0.66
- Revenue
- CVAC $599,540,810.00
- NMFC $340,877,000.00
- Revenue This Year
- CVAC N/A
- NMFC N/A
- Revenue Next Year
- CVAC $23.40
- NMFC N/A
- P/E Ratio
- CVAC $5.32
- NMFC $14.51
- Revenue Growth
- CVAC 675.15
- NMFC N/A
- 52 Week Low
- CVAC $2.37
- NMFC $8.84
- 52 Week High
- CVAC $5.72
- NMFC $12.05
- Technical
- Relative Strength Index (RSI)
- CVAC 51.18
- NMFC 49.70
- Support Level
- CVAC $5.17
- NMFC $9.50
- Resistance Level
- CVAC $5.41
- NMFC $9.70
- Average True Range (ATR)
- CVAC 0.05
- NMFC 0.16
- MACD
- CVAC -0.00
- NMFC 0.01
- Stochastic Oscillator
- CVAC 70.82
- NMFC 31.82
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.